WayPoint Biomedical Holdings Inc
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests fo… Read more
WayPoint Biomedical Holdings Inc (WYPH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2006: 0.427x
Based on the latest financial reports, WayPoint Biomedical Holdings Inc (WYPH) has a cash flow conversion efficiency ratio of 0.427x as of June 2006.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-143.33K) by net assets ($-335.91K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
WayPoint Biomedical Holdings Inc - Cash Flow Conversion Efficiency Trend (2004–2005)
This chart illustrates how WayPoint Biomedical Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
WayPoint Biomedical Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of WayPoint Biomedical Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sixty Six Oilfield Services Inc
PINK:SSOF
|
N/A |
|
Upper Street Marketing Inc
PINK:UPPR
|
-0.174x |
|
American Spectrum Realty Inc
PINK:AQQSQ
|
-0.100x |
|
Asia Carbon Industries Inc
PINK:ACRB
|
0.028x |
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
N/A |
|
Hypertension Diagnostics Inc
PINK:HDII
|
3.447x |
|
Alabama Aircraft Industries Inc
PINK:AAIIQ
|
-0.231x |
|
Orpheum Property Inc
PINK:PLFF
|
-0.009x |
Annual Cash Flow Conversion Efficiency for WayPoint Biomedical Holdings Inc (2004–2005)
The table below shows the annual cash flow conversion efficiency of WayPoint Biomedical Holdings Inc from 2004 to 2005.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2005-12-31 | $-417.88K | $0.00 | 0.000x | -- |
| 2004-12-31 | $-149.59K | $-88.24K | 0.590x | -- |